319
Participants
Start Date
September 3, 2020
Primary Completion Date
May 23, 2022
Study Completion Date
June 28, 2022
LX9211
Oral Tablets
LX9211 Matching Placebo
Oral Tablets
Lexicon Investigational Site, Williamsville
Lexicon Investigational Site, Westfield
Lexicon Investigational Site, Cary
Lexicon Investigational Site, Morehead City
Lexicon Investigational Site, Asheville
Lexicon Investigational Site, Greenville
Lexicon Investigational Site, Macon
Lexicon Investigational Site, Lake City
Lexicon Investigational Site, Ormond Beach
Lexicon Investigational Site, Jacksonville
Lexicon Investigational Site, Winter Park
Lexicon Investigational Site, Brandon
Lexicon Investigational Site, Fort Myers
Lexicon Investigational Site, New Port Richey
Lexicon Investigational Site, Mobile
Lexicon Investigational Site, Evansville
Lexicon Investigational Site, Ann Arbor
Lexicon Investigational Site, Dearborn
Lexicon Investigational Site, Sterling Heights
Lexicon Investigational Site, Farmington Hills
Lexicon Investigational Site, Hazelwood
Lexicon Investigational Site, Omaha
Lexicon Investigational Site, Flower Mound
Lexicon Investigational Site, Dallas
Lexicon Investigational Site, Houston
Lexicon Investigational Site, Houston
Lexicon Investigational Site, Pearland
Lexicon Investigational Site, Austin
Lexicon Investigational Site, Austin
Lexicon Investigational Site, Salt Lake City
Lexicon Investigational Site, Chandler
Lexicon Investigational Site, Glendale
Lexicon Investigational Site, Tucson
Lexicon Investigational Site, Kingman
Lexicon Investigational Site, Los Angeles
Lexicon Investigational Site, North Hollywood
Lexicon Investigational Site, Tustin
Lexicon Investigational Site, Anaheim
Lexicon Investigational Site, Greenbrae
Lexicon Investigational Site, Sacramento
Lexicon Investigational Site, Renton
Lexicon Investigational Site, Boston
Lexicon Investigational Site, South Dartmouth
Lexicon Investigational Site, Berlin
Lead Sponsor
Lexicon Pharmaceuticals
INDUSTRY